Hello, everyone, and how are you this morning? The sun is struggling to break through several days of gloom that has enveloped the Pharmalot corporate campus and we are celebrating with a deserved cup of stimulation. As you know, we are always looking for reasons to do so. Perhaps you feel the same. In any event, today will be another busy one, so time to get started. Here are a few interesting items and will update this post as we come across still more. Meanwhile, have a great day and drop us a line if you hear something interesting...
Generic Drug User Fees Q&A With The FDA (FDA FAQ)
AstraZeneca Establishes First Russian BioBank (Bio-IT World)
AstraZeneca Absorbs MedImmune Into Operations (Washington Business Journal)
Amgen's Aranesp For Anemia Fails To Help Heart Patients (Bloomberg News)
FDA Approves Egg-Free Flu Vaccine (Pharma Times)
Bond Market Likes Pfizer Animal Health Unit (Reuters)
Increasing Number Of Rare Disease Drugs Being Tested (Associated Press)
Genentech Takes Exelixis Med To Phase 3 Melanoma Trial (San Francisco Business Times)
FDA To Miss Decision Date On Hyperion Drug (San Francisco Business Times)
EDITOR'S NOTE: Please check this post later for additional items
sunrise pic thx to benimoto on flickr